National Research (NRC) has a profit margin of 4.48%, below the Healthcare sector average of 19.13%.
Get informed when a big investor buys or sells
+ FollowAs of Sep 2026
Trailing 12 months ending Sep 2026
The latest profit margin for NRC is 4.48% as of September 2026. That compares with 11.76% in the prior-year period — down 61.9% year over year. That is below the Healthcare sector average of 19.13%. Investors often review this figure alongside National Research's historical trend and sector peers before judging valuation or financial health.
Over the past year, NRC's profit margin moved from 11.76% to 4.48% — a 61.9% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in National Research's valuation or profitability profile.
Against Healthcare companies, NRC currently prints 4.48% for profit margin, while the sector average sits near 19.13%. That is roughly 76.6% below the sector mean. Large gaps often invite a closer look at National Research's growth, margins, and balance sheet.
Profit Margin shows how effectively National Research converts resources into returns. At 4.48%, NRC may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 11.76% in the prior-year period — down 61.9% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting NRC's profit margin (4.48%), review year-over-year change from 11.76%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.